Clinical Trial Update: Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ceftazidime-avibactam to standard of care in febrile neutropenic adults with cancer was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Febrile Neutropenia

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Forest Laboratories | Conditions: Neoplasms, Febrile Neutropenia | Phase 2 | Status: TERMINATED | Results posted: 2017-07-21